Skip to main content

Table 3 Mapping. Number of probe sets able to be mapped across datasets during independent validations.

From: Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

Cluster no.

Total probe sets present in classifier

Mapped

  

GUYT2 dataset

Ma dataset

Reid dataset

Jansen dataset

79

7

7

3

1

2

148

45

45

23

23

15

112

14

14

5

4

9

120

38

38

18

15

16

375

8

8

4

3

3

201

17

17

5

8

6

521

19

19

10

8

5

784

7

7

1

1

1

859

7

7

4

2

2

360

14

14

4

2

0

231

26

26

8

4

9

110

30

30

13

3

10

337

7

7

4

1

1

Total n (%)

239 (100%)

239 (100%)

102 (42.6%)

75 (31.4%)

73 (30.5%)